Marco Chávez-Tinoco

Dr. Marco Chávez-Tinoco


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2024 in Microbiology
Verified
Journal Article
Open access
MCMarco Chávez-Tinoco
Marco Chávez-Tinoco
LGLuis Garcia-Ortega
Luis Garcia-Ortega
EMEugenio Mancera
Eugenio Mancera
Candida maltosa is closely related to important pathogenic Candida species, especially C. tropicalis and C. albicans, but it has been rarely isolated from humans. For this reason, through comparative studies, it could be a powerful model to understand the genetic underpinnings of the pathogenicity of Candida species. Here, we generated a cohesive assembly of the C. maltosa genome and developed genetic engineering tools that will facilitate studying this species at a molecular level. We used a combination of short and long-read sequencing to build a polished genomic draft composed of 14 Mbp, 45 contigs and close to 5700 genes. This assembly represents a substantial improvement from the currently available sequences that are composed of thousands of contigs. Genomic comparison with C. albicans and C. tropicalis revealed a substantial reduction in the total number of genes in C. maltosa. However, gene loss seems not to be associated to the avirulence of this species given that most genes that have been previously associated with pathogenicity were also present in C. maltosa. To be able to edit the genome of C. maltosa we generated a set of triple auxotrophic strains so that gene deletions can be performed similarly to what has been routinely done in pathogenic Candida species. As a proof of concept, we generated gene knockouts of EFG1, a gene that encodes a transcription factor that is essential for filamentation and biofilm formation in C. albicans and C. tropicalis. Characterization of these mutants showed that Efg1 also plays a role in biofilm formation and filamentous growth in C. maltosa, but it seems to be a repressor of filamentation in this species. The genome assembly and auxotrophic mutants developed here are a key step forward to start using C. maltosa for comparative and evolutionary studies at a molecular level.

1 November 2025 in Journal of Nanotheranostics
Verified
Journal Article
Open access
PDF file
MCMarco Chávez-Tinoco
Marco Chávez-Tinoco
BSBruno Solís-Cruz
Bruno Solís-Cruz
Edgar R. López-MenaEdgar R. López-Mena
Edgar R. López-Mena
KGKarla S. Garcia-Salazar
Karla S. Garcia-Salazar
DHDaniel Hernandez-Patlan
Daniel Hernandez-Patlan
JMJorge L. Mejía-Méndez
Jorge L. Mejía-Méndez
Viral diseases remain a persistent threat to global health, agriculture, and biodiversity, as demonstrated by recent pandemics. The high mutation rates, diversity, and intricate replication mechanisms within a host can often challenge conventional detection and therapeutic approaches. The emergence of novel viruses underscores the critical importance of innovative and multidisciplinary strategies to outpace these diseases. In this context, nanotechnology has emerged as a transformative frontier, offering unique tools to address the limitations of traditional virology. This review examines the latest nanotechnological innovations designed to combat viral diseases. Like the development of advanced nanoplatforms, metallic and polymeric nanostructures, and carbon-based materials, and evaluating their roles in viral theranostics. This article provides critical biomedical insights into the function and relationship of nanomaterials, mechanisms of action, and their interaction with biological systems. This work aims to provide a valuable resource for guiding future research toward the clinical translation of nanomaterial-based strategies for the prevention, diagnosis, and treatment of viral infections.

2 July 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
JEJuan Esparza-Sánchez
Juan Esparza-Sánchez
DGDiego Alejandro Garibi-Miranda
Diego Alejandro Garibi-Miranda
MCMarco Chávez-Tinoco
Marco Chávez-Tinoco
JMJorge L. Mejía-Méndez
Jorge L. Mejía-Méndez
MSMaricruz Sepúlveda-Villegas
Maricruz Sepúlveda-Villegas
ALAngélica Lizeth Sánchez López
Angélica Lizeth Sánchez López
Background: Growing evidence suggests that chronic substance use disrupts the gut microbiota composition and function, which can contribute to intestinal dysfunction, systemic inflammation, and gut–brain axis dysregulation. However, current evidence remains fragmented and heterogenous, with most studies focusing on individual substances rather than substance-specific microbial signatures. Objective: Therefore, this systematic review synthesizes recent evidence (2019–2025) to characterize the impact of chronic substance use, including alcohol, nicotine, opioids, cocaine, and methamphetamine, on the gut microbiota composition and functional integrity. Methods: Following the PRISMA 2020 guidelines, a total of 91,421 records were identified before screening through searches conducted across electronic databases and publisher platforms, including PubMed, Web of Science, ProQuest, and BSCOhost, among others. After duplication removal and application of the predefined eligibility criteria, 60 studies were selected for qualitative analysis. Results: The findings revealed an interspecies similarity in which chronic substance exposure generally induced dysbiosis characterized by a depletion of beneficial short-chain fatty acid (SCFA)-producing taxa, such as Lactobacillus, Akkermansia, and Faecalibacterium, alongside the enrichment of opportunistic pathogens such as Escherichia-Shigella. Alcohol emerged as a particularly potent ecological driver, consistently reducing the richness and diversity of the microbial community. Mechanistically, these alterations are linked to impaired intestinal barrier function, increased lipopolysaccharide translocation, and the activation of systemic inflammatory pathways. Furthermore, substance-specific metabolic fingerprints were identified, including disruptions in glutamate pathways for cocaine and trimethylamine N-oxide precursors for methamphetamine. Preclinical evidence from fecal microbiota transplantation and germ-free models suggests that these microbial shifts actively modulate reward sensitivity and neuroplasticity through the gut–brain axis. Conclusion: Collectively, the data presented in this study support a shift from reductionist addiction models toward a systems-level framework, positioning the gut microbiome as a pivotal, modifiable component of addiction biology and a promising target for novel therapeutic interventions.

9 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MCMarco Chávez-Tinoco
Marco Chávez-Tinoco
LGLuis Garcia-Ortega
Luis Garcia-Ortega
EMEugenio Mancera
Eugenio Mancera
Candida maltosa is closely related to important pathogenic Candida species, but it has been rarely isolated from humans. Therefore, through comparative studies, it could be a powerful model to understand the pathogenicity underpinnings of Candida species. To facilitate studying C. maltosa at a molecular level, we built a cohesive genomic sequence composed of 45 scaffolds, a substantial improvement from the thousands of contigs of the available draft. Comparison with C. albicans and C. tropicalis revealed a reduction in the total number of genes in C. maltosa . However, gene loss seems not to be associated to its avirulence given that most pathogenicity genes were also present in C. maltosa . To genetically edit C. maltosa we generated triple auxotrophic strains so that gene deletions can be performed as has been routinely done in pathogenic species. As a proof of concept, we generated gene knockouts of Efg1, a transcription regulator involved in filamentation and biofilm formation in pathogenic species. Although in C. maltosa Efg1 also played a role in these processes, it seems to rather be a repressor of filamentation. The genome assembly and auxotrophic mutants developed are a key step to start using C. maltosa for comparative studies at a molecular level.

17 December 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
YCYulianna Minutti Calva
Yulianna Minutti Calva
KSKaren Schürenkämper-Carrillo
Karen Schürenkämper-Carrillo
EREdwin Estefan Reza-Zaldivar
Edwin Estefan Reza-Zaldivar
OROscar Enrique Del Razo-Rodríguez
Oscar Enrique Del Razo-Rodríguez
IVIan Vitola
Ian Vitola
ESEugenio Sánchez-Arreola
Eugenio Sánchez-Arreola
Background: Equisetum hyemale L., commonly known as scouring rush or horsetail, is a perennial plant with significant applications in traditional medicine. Methods: The aerial parts of E. hyemale L. were macerated with hexane, chloroform, and ethyl acetate. The phytochemical profile of the extracts was investigated using chromatography approaches. The biological performance of the extracts was determined using antibacterial, antioxidant, anticancer, and toxicity in vitro and in vivo models. Molecular docking and ADMET analyses were employed to determine interactions with structural components of multidrug resistant bacteria and assess potential toxicological risks. Results: The extracts exert high scavenging activity against ABTS radicals (IC50 2.57–2.68 μg/mL), but poor antibacterial activity. It was evidenced that treatment with extracts exerts in moderate cytotoxicity on hepatocellular and colorectal cancer cell lines. Toxicity assays unveiled that the extracts decrease the survival rate of C. elegans nematodes after 2 h of exposure to treatment. In silico studies evidenced a high affinity of campesterol and calcitriol towards the DNA gyrase, and the oral bioavailability of farnesol and limonene. Conclusions: Our findings demonstrated the presence of biologically active secondary metabolites in hexane, chloroform, and ethyl acetate extracts from E. hyemale L. This work also demonstrated the biological performance of these extracts in in vitro and in vivo models, and validated the potential pharmacokinetic and pharmacodynamic profile of their phytoconstituents.